Cargando…

Tocilizumab for Covid-19 — The Ongoing Search for Effective Therapies

Detalles Bibliográficos
Autores principales:	Huang, Edmund, Jordan, Stanley C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Massachusetts Medical Society 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745168/ https://www.ncbi.nlm.nih.gov/pubmed/33296566 http://dx.doi.org/10.1056/NEJMe2032071

Ejemplares similares

Tocilizumab and COVID-19
por: Chaudhry, Dhruva, et al.
Publicado: (2020)

Time for tocilizumab in COVID-19?
por: Butler, Ethan, et al.
Publicado: (2021)

Tocilizumab treatment in critically ill patients with COVID-19: A retrospective observational study
por: Huang, Edmund, et al.
Publicado: (2021)

Tocilizumab in COVID-19: Is the Temptation Worthwhile?
por: Gupta, Sachin, et al.
Publicado: (2021)

One year later: The case of tocilizumab in COVID-19
por: Campochiaro, Corrado, et al.
Publicado: (2022)

Covid-19 — The Search for Effective Therapy
por: Baden, Lindsey R., et al.
Publicado: (2020)

Response of Clinical Laboratories to the Ongoing COVID-19 Pandemic
por: Kim, Young Jin, et al.
Publicado: (2021)

COVID-19: an ongoing public health crisis in the Philippines
Publicado: (2021)

Venous thromboembolism and COVID-19 patients: An ongoing story
por: Emmerich, J.
Publicado: (2021)

COVID-19 : encore une place pour le tocilizumab ?
por: Richier, Q., et al.
Publicado: (2021)

No country or continent is on its own in the ongoing COVID-19 pandemic
por: Johansen, Kari, et al.
Publicado: (2021)

Ongoing challenges three years after the start of the COVID-19 pandemic
por: Moore, David, et al.
Publicado: (2023)

The ongoing search for simplifying fractional flow reserve assessment: the role of contrast medium
por: Cialdella, Pio, et al.
Publicado: (2016)

What's New in Critical Illness and Injury Science? Mortality effects of tocilizumab for patients admitted with COVID-19 pneumonia
por: Miller, Andrew C., et al.
Publicado: (2021)

Initial and ongoing challenges with COVID-19-associated mucormycosis
por: Sikka, Kapil, et al.
Publicado: (2021)

Diabetes and COVID-19: What we learned from the two ongoing pandemics
por: Torquato, Maria Teresa da Costa Gonçalves, et al.
Publicado: (2021)

Ongoing COVID-19 pandemic and medical education: Pros and cons
por: Chowdhury, Tumul, et al.
Publicado: (2022)

An ongoing search for potential targets and therapies for lethal sepsis
por: Bao, Guo-qiang, et al.
Publicado: (2015)

The ongoing COVID-19 pandemic will create a disease surge among cancer patients
por: Meyer, Michael, et al.
Publicado: (2020)

Tocilizumab: An Effective Therapy for Severely and Critically Ill COVID-19 Patients
por: Bhandari, Sudhir, et al.
Publicado: (2021)

Tocilizumab in COVID-19 therapy: who benefits, and how?
por: Yang, Chengliang, et al.
Publicado: (2021)

Tocilizumab in COVID-19 therapy: who benefits, and how?
por: Neumann, Avidan U, et al.
Publicado: (2021)

Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients
por: Marfella, R., et al.
Publicado: (2020)

Tuberculosis: an ongoing global epidemic
Publicado: (2021)

Obesity: another ongoing pandemic
por: The Lancet Gastroenterology & Hepatology
Publicado: (2021)

Editorial: Tocilizumab, a Humanized Therapeutic IL-6 Receptor (IL-6R) Monoclonal Antibody, and Future Combination Therapies for Severe COVID-19
por: Parums, Dinah V.
Publicado: (2021)

Hydroxychloroquine and tocilizumab therapy in COVID-19 patients—An observational study
por: Ip, Andrew, et al.
Publicado: (2020)

Tocilizumab in severe COVID-19
por: Lucio Liberato, Nicola, et al.
Publicado: (2020)

Tocilizumab therapy for COVID-19: A comparison of subcutaneous and intravenous therapies
por: Kaminski, Monica A., et al.
Publicado: (2020)

Tocilizumab for hospitalized patients with COVID-19
por: Afra, Kevin, et al.
Publicado: (2021)

Thromboinflammation response to tocilizumab in COVID‐19
por: Gergi, Mansour, et al.
Publicado: (2020)

Benchmarking tocilizumab use for giant cell arteritis
por: Conway, Richard, et al.
Publicado: (2022)

The ongoing nosologic dilemma with the metabolic syndrome
por: Vaidya, Ashok D. B.
Publicado: (2010)

THE MENTAL HEALTH LEGISLATION:AN ONGOING DEBATE
por: Trivedi, J.K.
Publicado: (2002)

The ongoing and worldwide challenge of pediatric trauma
por: Sharar, Sam R
Publicado: (2012)

Refugee Health: An Ongoing Commitment and Challenge
por: Efird, Jimmy T., et al.
Publicado: (2018)

The Ongoing Evolution of Abdominal Aortic Surgery
por: Oikonomou, Kyriakos, et al.
Publicado: (2022)

The technical toolbox for controlling ongoing hemorrhage
por: Ball, Chad G., et al.
Publicado: (2023)

Liquid Biopsy and Cancer: An Ongoing Story
por: Di Zazzo, Erika, et al.
Publicado: (2023)

Type 2 diabetic Asian Indians and COVID-19: Lessons learnt so far from the ongoing pandemic
por: Shivane, VK, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jk48eutk21c4gsf0apd3fth70d